# McMaster Children's Hospital: Phase 3 study in Appendicitis Perforated, Appendectomy, Laparoscopic (180 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | McMaster Children's Hospital |
| Sponsor type | Academic and hospital |
| Study | Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis |
| NCT ID | NCT07869095 |
| Phase | Phase 3 |
| Status | not yet recruiting |
| Conditions | Appendicitis Perforated; Appendectomy, Laparoscopic; Antibiotic; Pediatric; Randomized Controlled Trial |
| Intervention types | drug |
| Target enrollment | 180 |
| Posted | 2026-10-09 |
| Planned start | 2027-04 |
| Event | Newly registered study |
| Event date | 2026-10-09 |

## Why this score
- Phase 3: multi-site, larger budget.
- 180 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07869095). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.